Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dodick

Showing results (281-290 of 365) with videos related to

Pageof 37
Sort By:
Headache|June 3, 2021
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequencyRyotaro Ishii, Todd J Schwedt, Gina Dumkrieger, et al.
JAMA Network Open|June 8, 2022
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache|February 14, 2020
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatmentDavid W Dodick, Peter J Goadsby, Christian Lucas, et al.
JAMA Neurology|December 20, 2017
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical TrialVladimir Skljarevski, Tina M Oakes, Qi Zhang, et al.
Mayo Clinic Proceedings|July 13, 2005
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatmentRoger K Cady, David W Dodick, Howard L Levine, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 28, 2006
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headacheHoward L Levine, Michael Setzen, Roger K Cady, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
Baseline Normative and Test-Retest Reliability Data for Sideline Concussion Assessment Measures in YouthJennifer V Wethe, Jamie Bogle, David W Dodick, et al.
Pain|July 20, 2012
Activation of TRPA1 on dural afferents: a potential mechanism of headache painRebecca M Edelmayer, Larry N Le, Jin Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2025
A prolactin-targeting antibody to prevent stress-induced peripheral nociceptor sensitization and female postoperative painHarrison J Stratton, Mahdi Dolatyari, Carol Kopruszinski, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trialDavid W Dodick, Peter J Goadsby, Stephen D Silberstein, et al.
Pageof 37

Showing results (281-290 of 365) with videos related to

Sort By:
Pageof 37
Headache|June 3, 2021
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequencyRyotaro Ishii, Todd J Schwedt, Gina Dumkrieger, et al.
JAMA Network Open|June 8, 2022
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache|February 14, 2020
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatmentDavid W Dodick, Peter J Goadsby, Christian Lucas, et al.
JAMA Neurology|December 20, 2017
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical TrialVladimir Skljarevski, Tina M Oakes, Qi Zhang, et al.
Mayo Clinic Proceedings|July 13, 2005
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatmentRoger K Cady, David W Dodick, Howard L Levine, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 28, 2006
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headacheHoward L Levine, Michael Setzen, Roger K Cady, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
Baseline Normative and Test-Retest Reliability Data for Sideline Concussion Assessment Measures in YouthJennifer V Wethe, Jamie Bogle, David W Dodick, et al.
Pain|July 20, 2012
Activation of TRPA1 on dural afferents: a potential mechanism of headache painRebecca M Edelmayer, Larry N Le, Jin Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2025
A prolactin-targeting antibody to prevent stress-induced peripheral nociceptor sensitization and female postoperative painHarrison J Stratton, Mahdi Dolatyari, Carol Kopruszinski, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trialDavid W Dodick, Peter J Goadsby, Stephen D Silberstein, et al.
Pageof 37